Holobiome Company

Owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety and other mental health problems including our metabolism and the immune response, enabling patients to recover quickly from their diseases easily without any pain and suffering.

Founded Date: 2015-01-01
Total Funding: $10K
Employee Number: 1-10
Funding Status: Seed
Technology: NeuroTech
Last Funding Type: Seed
Investors Number: 2
Industry: Therapeutics
Headquarters: Cambridge, Massachusetts, United States